Emma Peruga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emma Peruga has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Francisco García-García
Computational Biomedicine Laboratory, Principe Felipe Research Center (CIPF)
1 shared publication - Glòria Garrabou
Inherited Metabolic Diseases and Muscular Disorders Research Group Department of Internal Medicine‐Hospital Clínic of Barcelona (HCB) Faculty of Medicine and Health Science University of Barcelona (UB) Barcelona Catalonia Spain
1 shared publication - Judith Cantó-Santos
Muscle Research and Mitochondrial Function Laboratory, CELLEX-IDIBAPS, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain
1 shared publication - Laia Rodriguez-Revenga
Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona, 08036 Barcelona, Spain
1 shared publication - Laura Gort
Division of Inborn Errors of Metabolism-IBC, Department of Biochemistry and Molecular Genetics, CDB, Hospital Clínic de Barcelona, 08036 Barcelona, Spain
1 shared publication - Maria Isabel Alvarez-Mora
Department of Biochemistry and Molecular Genetics, Hospital Clinic of Barcelona
1 shared publication
Latest Publications
- Open Access
- 8 June 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (6) , 1129
Bioenergetic and Autophagic Characterization of Skin Fibroblasts from C9orf72 Patients
The objective of this study is to describe the alterations occurring during the neurodegenerative process in skin fibroblast cultures from C9orf72 patients. We characterized the oxidative stress, autophagy flux, small ubiquitin-related protein SUMO2/3 levels as well as the mitochondrial function in skin fibroblast cultures from C9orf72 patients. All metabolic and bioenergetic findings were further correlated with gene expression data obtained from RNA sequencing analysis. Fibroblasts from C9orf72 patients showed a 30% reduced expression of C9orf72, ~3-fold increased levels of oxidative stress and impaired mitochondrial function obtained by measuring the enzymatic activities of mitochondrial respiratory chain complexes, specifically of complex III activity. Furthermore, the results also reveal that C9orf72 patients showed an accumulation of p62 protein levels, suggesting the alteration of the autophagy process, and significantly higher protein levels of SUMO2/3 (p = 0.03). Our results provide new data reinforcing that C9orf72 cells suffer from elevated oxidative damage to biomolecules and organelles and from increased protein loads, leading to insufficient autophagy and an increase in SUMOylation processes.
- 8 June 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (6) , 1129
Open AccessBioenergetic and Autophagic Characterization of Skin Fibroblasts from C9orf72 Patients
The objective of this study is to describe the alterations occurring during the neurodegenerative process in skin fibroblast cultures from C9orf72 patients. We characterized the oxidative stress, autophagy flux, small ubiquitin-related protein SUMO2/3 levels as well as the mitochondrial function in skin fibroblast cultures from C9orf72 patients. All metabolic and bioenergetic findings were further correlated with gene expression data obtained from RNA sequencing analysis. Fibroblasts from C9orf72 patients showed a 30% reduced expression of C9orf72, ~3-fold increased levels of oxidative stress and impaired mitochondrial function obtained by measuring the enzymatic activities of mitochondrial respiratory chain complexes, specifically of complex III activity. Furthermore, the results also reveal that C9orf72 patients showed an accumulation of p62 protein levels, suggesting the alteration of the autophagy process, and significantly higher protein levels of SUMO2/3 (p = 0.03). Our results provide new data reinforcing that C9orf72 cells suffer from elevated oxidative damage to biomolecules and organelles and from increased protein loads, leading to insufficient autophagy and an increase in SUMOylation processes.